Vilazodone: Clinical Trials

8 trials of Vilazodone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 terminated, 1 withdrawn. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 6, Terminated 1, Withdrawn 1

Follow Vilazodone: new trials by email Literature Review of Vilazodone trials Research Report on Vilazodone

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vilazodone for Separation Anxiety Disorder
Vilazodone, Placebo - Separation Anxiety Disorder
Phase 4CompletedNew York State Psychiatric Institute242013-12-012018-03-07
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Vilazodone, Citalopram - Major Depressive Disorder, Anxiety
Phase 4WithdrawnMassachusetts General Hospital2013-04-012016-11-08
Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?
Vilazodone, Sertraline - Sexual Dysfunction, Major Depressive Disorder
Phase 4TerminatedThomas Jefferson University42013-01-012016-08-25
Vilazodone for the Treatment of Posttraumatic Stress Disorder
Treatment (Viibryd) - PTSD, Depression
Phase 4CompletedSouthern California Institute for Research and Education592012-10-012017-04-25
Vilazodone for Treatment of Geriatric Depression
Vilazodone; Viibryd, Paroxetine; Paxil - Major Depressive Disorder
Phase 4CompletedUniversity of California, Los Angeles652012-07-012018-05-11
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Placebo, Vilazodone - Major Depressive Disorder
Phase 4CompletedForest Laboratories12192012-04-012015-05-18
Safety and Efficacy of Vilazodone in Major Depressive Disorder
Vilazodone, Placebo to citalopram, Placebo to vilazodone - Major Depressive Disorder
Phase 4CompletedForest Laboratories11622011-12-012014-08-08
Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder
Dose-matched placebo, Vilazodone - Major Depressive Disorder
Phase 4CompletedForest Laboratories5182011-12-012014-04-03

Conditions studied

Depressive Disorder, Major (6)  ·  Depression (5)  ·  Anxiety Disorders (2)  ·  Anxiety, Separation (1)  ·  Consciousness Disorders (1)  ·  Depressive Disorder (1)  ·  Sexual Dysfunction, Physiological (1)  ·  Stress Disorders, Post-Traumatic (1)

Sponsors

Forest Laboratories (3)  ·  Massachusetts General Hospital (1)  ·  New York State Psychiatric Institute (1)  ·  Southern California Institute for Research and Education (1)  ·  Thomas Jefferson University (1)  ·  University of California, Los Angeles (1)

Countries

United States (8)  ·  Bulgaria (1)  ·  Finland (1)  ·  Germany (1)  ·  Romania (1)  ·  Russia (1)  ·  Serbia (1)  ·  Ukraine (1)

Top investigators

Carl Gommoll, MS (2)  ·  Anita Clayton, MD (1)  ·  Carrie Reichley (1)  ·  Franklin Schneier, MD (1)  ·  Helen Lavretsky, M.D. (1)  ·  Michael E Henry, MD (1)  ·  Michael Thase, MD (1)  ·  Rajnish Mago, MD (1)

Results publications

PMID 29608461, PMID 25396353, PMID 25470094, PMID 25500685, PMID 26039688, PMID 26693034, PMID 28858440, PMID 29071764